ICU

Company Overview — What Does SeaStar Medical Holding Corp Do?

LMF Acquisition Opportunities, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Tampa, Florida. SeaStar Medical Holding Corp (ICU) is classified as a micro-cap stock in the Healthcare sector, specifically within the Medical Equipment industry. The company is led by CEO Eric Schlorff and employs approximately 2 people. With a market capitalization of $14M, ICU is one of the notable companies in the Healthcare sector.

SeaStar Medical Holding Corp (ICU) Stock Rating — Reduce (April 2026)

As of April 2026, SeaStar Medical Holding Corp receives a Reduce rating with a composite score of 28.5/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.ICU ranks #2,611 out of 4,446 stocks in our coverage universe. Within the Healthcare sector, SeaStar Medical Holding Corp ranks #341 of 838 stocks, placing it in the upper half of its Healthcare peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

ICU Stock Price and 52-Week Range

SeaStar Medical Holding Corp (ICU) currently trades at $3.67. The stock lost $0.39 (9.6%) in the most recent trading session. The 52-week high for ICU is $2.98, which means the stock is currently trading 23.2% from its annual peak. The 52-week low is $0.22, putting the stock 1568.2% above its annual trough. Recent trading volume was 166K shares, suggesting relatively thin trading activity.

Is ICU Overvalued or Undervalued? — Valuation Analysis

SeaStar Medical Holding Corp (ICU) carries a value factor score of 11/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 1.60x, versus the sector average of 2.75x. The price-to-sales ratio is 18.88x, compared to 1.66x for the average Healthcare stock.

At current multiples, SeaStar Medical Holding Corp trades at a premium to most Healthcare peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

SeaStar Medical Holding Corp Profitability — ROE, Margins, and Quality Score

SeaStar Medical Holding Corp (ICU) earns a quality factor score of 14/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -131.8%, compared to the Healthcare sector average of -43.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -96.9% versus the sector average of -33.1%.

On a margin basis, SeaStar Medical Holding Corp reports gross margins of 96.1%, compared to 71.5% for the sector. The operating margin is -2583.2% (sector: -66.1%). Net profit margin stands at -2590.6%, versus -58.7% for the average Healthcare stock. Revenue growth is running at 169.1% on a trailing basis, compared to 10.6% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

ICU Debt, Balance Sheet, and Financial Health

SeaStar Medical Holding Corp has a debt-to-equity ratio of 36.0%, compared to the Healthcare sector average of 32.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 3.63x, indicating strong short-term liquidity. Total debt on the balance sheet is $0. Cash and equivalents stand at $14M.

ICU has a beta of 1.89, meaning it is more volatile than the broader market — a $10,000 investment in ICU would be expected to move 89.5% more than the S&P 500 on any given day. The stability factor score for SeaStar Medical Holding Corp is 7/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

SeaStar Medical Holding Corp Revenue and Earnings History — Quarterly Trend

In TTM 2026, SeaStar Medical Holding Corp reported revenue of $882,000 and earnings per share (EPS) of $-5.86. Net income for the quarter was $-14M. Gross margin was 96.1%. Operating income came in at $-14M.

In FY 2025, SeaStar Medical Holding Corp reported revenue of $1M and earnings per share (EPS) of $-5.86. Net income for the quarter was $-12M. Gross margin was 95.7%. Revenue grew 814.1% year-over-year compared to FY 2024. Operating income came in at $-12M.

In Q3 2025, SeaStar Medical Holding Corp reported revenue of $183,000 and earnings per share (EPS) of $-0.13. Net income for the quarter was $-3M. Gross margin was 92.3%. Revenue grew 169.1% year-over-year compared to Q3 2024. Operating income came in at $-4M.

In Q2 2025, SeaStar Medical Holding Corp reported revenue of $338,000 and earnings per share (EPS) of $-0.18. Net income for the quarter was $-2M. Gross margin was 92.0%. Operating income came in at $-2M.

Over the past 8 quarters, SeaStar Medical Holding Corp has demonstrated a growth trajectory, with revenue expanding from $0 to $882,000. Investors analyzing ICU stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

ICU Dividend Yield and Income Analysis

SeaStar Medical Holding Corp (ICU) does not currently pay a dividend. This is common among smaller companies in the Medical Equipment industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Healthcare dividend stocks may want to explore other Healthcare stocks or use the stock screener to filter by dividend yield.

ICU Momentum and Technical Analysis Profile

SeaStar Medical Holding Corp (ICU) has a momentum factor score of 61/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 25/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 42/100 reflects moderate short selling activity.

ICU vs Competitors — Healthcare Sector Ranking and Peer Comparison

Within the Healthcare sector, SeaStar Medical Holding Corp (ICU) ranks #341 out of 838 stocks based on the Blank Capital composite score. This places ICU in the upper half of all Healthcare stocks in our coverage universe. Key competitors and sector peers include ASTRAZENECA PLC (AZN) with a score of 61.4/100, Sol-Gel Technologies Ltd. (SLGL) with a score of 56.6/100, VIEMED HEALTHCARE, INC. (VMD) with a score of 53.4/100, Innoviva, Inc. (INVA) with a score of 52.7/100, and JOHNSON & JOHNSON (JNJ) with a score of 51.7/100.

Comparing ICU against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full ICU vs S&P 500 (SPY) comparison to assess how SeaStar Medical Holding Corp stacks up against the broader market across all factor dimensions.

ICU Next Earnings Date

No upcoming earnings date has been announced for SeaStar Medical Holding Corp (ICU) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy ICU? — Investment Thesis Summary

The quantitative profile for SeaStar Medical Holding Corp suggests caution. The quality score of 14/100 flags below-average profitability. The value score of 11/100 indicates premium valuation. Price momentum is positive at 61/100, suggesting the trend favors buyers. High volatility (stability score 7/100) increases portfolio risk.

In summary, SeaStar Medical Holding Corp (ICU) earns a Reduce rating with a composite score of 28.5/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on ICU stock.

Related Resources for ICU Investors

Explore more research and tools: ICU vs S&P 500 comparison, top Healthcare stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare ICU head-to-head with peers: ICU vs AZN, ICU vs SLGL, ICU vs VMD.